ArticleBioMed research international2015

The oncofetal protein IMP3: a novel grading tool and predictor of poor clinical outcome in human gliomas.

Alessandro Del Gobbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.